Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.85 EUR | +0.15% | +0.22% | +99.56% |
04-11 | Health Care Slips on Risk Bias -- Health Care Roundup | DJ |
04-11 | Trending : Novartis Begins Tender Offer for MorphoSys Shares | DJ |
Business Summary
Number of employees: 524
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Cancer Medicines
100.0
%
| 278 | 100.0 % | 238 | 100.0 % | -14.37% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
88.8
%
| 0 | 0.0 % | 211 | 88.8 % | - |
Europe (excluding Germany)
11.2
%
| - | - | 27 | 11.2 % | - |
Asia
0.0
%
| - | - | 0 | 0.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jean-Paul Kress
CEO | Chief Executive Officer | 59 | 31/08/19 |
Lucinda Crabtree
DFI | Director of Finance/CFO | 45 | 06/08/23 |
Luisa Ciccarelli
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/21 |
Tim Demuth
CTO | Chief Tech/Sci/R&D Officer | 50 | 30/09/22 |
Julia Neugebauer
IRC | Investor Relations Contact | - | 31/08/06 |
Daniel Palmacci
PRN | Corporate Officer/Principal | - | 30/06/20 |
Ann Merchant
PRN | Corporate Officer/Principal | 59 | 31/12/17 |
Ralf Ostendorp
PRN | Corporate Officer/Principal | - | 31/12/98 |
Corporate Officer/Principal | - | 30/04/94 | |
Klaus de Wall
AUD | Comptroller/Controller/Auditor | - | 31/05/05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Brosnan
BRD | Director/Board Member | 69 | 16/05/18 |
Director/Board Member | 67 | 16/05/18 | |
Marc Cluzel
CHM | Chairman | 69 | 30/05/12 |
Andrew Cheng
BRD | Director/Board Member | 57 | 17/05/22 |
Krisja Vermeylen
BRD | Director/Board Member | 62 | 31/12/16 |
Sharon Curran
BRD | Director/Board Member | 56 | 21/05/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 37,716,423 | 31,528,877 ( 83.59 %) | 53,685 ( 0.1423 %) | 83.59 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+99.56% | 2.73B | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- MOR Stock
- Company MorphoSys AG